Select Medical (NYSE:SEM) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, February 22nd. Analysts expect the company to announce earnings of $0.19 per share for the quarter.

Shares of Select Medical (NYSE:SEM) opened at $16.55 on Thursday. The stock has a market cap of $2,210.00, a price-to-earnings ratio of 22.99, a PEG ratio of 1.04 and a beta of 1.30. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 3.36. Select Medical has a 52-week low of $12.00 and a 52-week high of $19.77.

In other Select Medical news, insider Martin F. Jackson sold 134,029 shares of the stock in a transaction on Friday, December 22nd. The shares were sold at an average price of $17.05, for a total transaction of $2,285,194.45. Following the transaction, the insider now directly owns 1,717,944 shares in the company, valued at approximately $29,290,945.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Scott A. Romberger sold 5,000 shares of the stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $17.97, for a total transaction of $89,850.00. Following the transaction, the insider now owns 168,211 shares in the company, valued at $3,022,751.67. The disclosure for this sale can be found here. Insiders sold 295,955 shares of company stock valued at $5,052,199 over the last 90 days. Insiders own 19.93% of the company’s stock.

SEM has been the subject of several analyst reports. Zacks Investment Research downgraded shares of Select Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, December 13th. Robert W. Baird set a $25.00 target price on shares of Select Medical and gave the company a “buy” rating in a research note on Monday, October 23rd. Bank of America upgraded shares of Select Medical from an “underperform” rating to a “neutral” rating and set a $19.00 target price for the company in a research note on Thursday, January 4th. Deutsche Bank restated a “buy” rating and issued a $22.00 target price on shares of Select Medical in a research note on Monday, November 6th. Finally, ValuEngine upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $20.25.

TRADEMARK VIOLATION WARNING: This piece was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://theolympiareport.com/2018/02/15/select-medical-sem-scheduled-to-post-earnings-on-thursday.html.

About Select Medical

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Earnings History for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.